Side-by-side financials for BTMD and DFTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BTMD | DFTX |
|---|---|---|
| Market cap | - | $2.65 B |
| US-listed rank | - | #1913 |
| Revenue (latest FY) | $192.22M | - |
| Net income (latest FY) | $27.05M | -$183.79M |
| Net margin | 14.1% | - |
| SEC filings | 398 | 445 |
Full pages: biote Corp. and Definium Therapeutics, Inc., or browse the full rankings.